Flutialfa F 125 Inhaler combines two powerful medications, Formoterol (6mcg), a long-acting beta-agonist (LABA), and Fluticasone Propionate (125mcg), a corticosteroid, to provide effective relief and management for chronic respiratory conditions such as Asthma and Chronic Obstructive Pulmonary Disease (COPD).
Formoterol works by relaxing the muscles in the airways, thereby easing breathing, while Fluticasone Propionate reduces inflammation within the airways, preventing asthma attacks and controlling symptoms of COPD. Together, they offer a dual action of bronchodilation and anti-inflammatory effects, helping patients manage symptoms over time.
Flutialfa F 125 Inhaler is intended for long-term control and prevention of asthma and COPD symptoms. It should be used regularly, as prescribed by your healthcare provider, to help keep symptoms under control. It is not meant for the immediate relief of acute breathing problems or asthma attacks.
This inhaler should be part of a comprehensive treatment plan, which may include other medications for acute symptoms or other conditions. Patients should be monitored regularly to ensure that the medication is working effectively.